April 25, 2008 - EPIX Pharmaceuticals Inc. met all pre-specified endpoints prospectively agreed to with the FDA in a blinded, independent re-read of images of its novel blood pool magnetic resonance angiographic (MRA) agent, Vasovist (gadofosveset trisodium), and plans to resubmit a New Drug Application (NDA) to the FDA for Vasovist in mid-2008.

April 25, 2008 - The Society for Cardiovascular Angiography and Interventions (SCAI) and the American College of Cardiology (ACC) will return to the traditional individual meeting formats for both the SCAI Annual Scientific Sessions and i2 Summit in 2009, in response to SCAI members' request for more a intimate meeting.

In 2008, SCAI and ACC partnered to hold the SCAI Annual Scientific Sessions in Partnership with ACCi2 Summit (SCAI-ACCi2), held in conjunction with ACC's Annual Scientific Session in Chicago.

April 25, 2008 - CV Therapeutics reported the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) recommended approval of ranolazine in the European Union (EU) for the treatment of chronic angina.

April 25, 2008 - An everolimus-eluting stent compared with a paclitaxel-eluting stent resulted in reduced angiographic late loss, noninferior rates of target vessel failure, and fewer major adverse cardiac events during one-year of follow-up in a recent study published in JAMA.

Gregg W. Stone, M.D. (Columbia University Medical Center and the Cardiovascular Research Foundation, New York) and colleagues aimed to evaluate the safety and efficacy of an everolimus-eluting stent compared with a widely used paclitaxel-eluting stent.

April 24, 2008 - Boston Scientific Corp. completed enrollment in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT), engineered to test whether CRT-Ds can slow the progression of heart failure in heart attack survivors and in those with other forms of impaired heart function.

April 24, 2008 - ProSolv CardioVascular, a FUJIFILM company, will interface its cardiovascular image and information system (CVIIS) with QLAB, 2D and 3D ultrasound quantification tools software from Philips.

Facilities using Philips ultrasound systems will now have access to Philips' QLAB advanced 2D and 3D ultrasound quantification tools within the ProSolv CardioVascular application, designed to deliver efficiency benefits for clinicians and enhancing the accuracy of diagnosis.

April 24, 2008 - Using 3D ultrasound technology they designed, Duke University bioengineers can compensate for the thickness and unevenness of the skull to see in real time the arteries within the brain that most often clog up and cause strokes.

April 24, 2008 - Medicare Part B will now cover and pay for meter training, equipment and supplies for most long-term warfarin users who monitor their own PT/INR results at home with portable meters, expanding coverage to include those on anticoagulant medication with chronic atrial fibrillation (AF) and venous thromboembolism.

April 24, 2008 - SynCardia Systems Inc., the manufacturer of the CardioWest temporary Total Artificial Heart (TAH-t), has recognized Mayo Clinic Arizona and Virginia Commonwealth University Medical Center as 'CardioWest 100 Percent Centers for 2007' for a 100 percent success rate in CardioWest artificial heart implants in 2007.

The AutoPulse Non-invasive Cardiac Support Pump is an automated, portable device with an easy-to-use, load-distributing LifeBand that squeezes the entire chest, improving blood flow to the heart and brain during sudden cardiac arrest (SCA).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now